Case File
efta-efta01582865DOJ Data Set 10CorrespondenceEFTA Document EFTA01582865
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-efta01582865
Pages
0
Persons
0
Integrity
Loading PDF viewer...
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
8742
Management consulting services
EXECUTIVES
CEO:
JEFFREY EPSTEIN, PRESIDENT
************** ***** *mamma*
EMPLOYEES **********************************
Employees at this location:
Employees Total:
16 - Actual
16 - Actual
************* ***** ********** OTHER INFORMATION ************** ****** ***********
REGION: NORTH AMERICA
LANGUAGE: ENGLISH
LOAD-DATE: March 05, 2003
[PAGE
Confidential Treatment Requested by JPMorgan Chase
JPM-SDNY-00062445
EFTA01582865
Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.